Arthur F. Ryan - 01 Nov 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Nov 2022
Net transactions value
-$75,589
Form type
4
Filing time
03 Nov 2022, 16:03:42 UTC
Previous filing
05 Oct 2022
Next filing
02 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,500 -2 -0.01% $750.00 19,480 01 Nov 2022 Direct F1
transaction REGN Common Stock Sale $4,516 -6 -0.03% $752.59 19,474 01 Nov 2022 Direct F1, F2
transaction REGN Common Stock Sale $7,537 -10 -0.05% $753.68 19,464 01 Nov 2022 Direct F1, F3
transaction REGN Common Stock Sale $9,057 -12 -0.06% $754.73 19,452 01 Nov 2022 Direct F1, F4
transaction REGN Common Stock Sale $13,599 -18 -0.09% $755.50 19,434 01 Nov 2022 Direct F1, F5
transaction REGN Common Stock Sale $19,664 -26 -0.13% $756.31 19,408 01 Nov 2022 Direct F1, F6
transaction REGN Common Stock Sale $11,364 -15 -0.08% $757.58 19,393 01 Nov 2022 Direct F1, F7
transaction REGN Common Stock Sale $3,033 -4 -0.02% $758.16 19,389 01 Nov 2022 Direct F1, F8
transaction REGN Common Stock Sale $3,798 -5 -0.03% $759.61 19,384 01 Nov 2022 Direct F1, F9
transaction REGN Common Stock Sale $1,522 -2 -0.01% $761.00 19,382 01 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2022 at prices ranging from $752.28 to $752.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 10 shares of Company stock on November 1, 2022 at prices ranging from $753.23 to $753.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 12 shares of Company stock on November 1, 2022 at prices ranging from $754.06 to $754.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 18 shares of Company stock on November 1, 2022 at prices ranging from $755.11 to $755.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 26 shares of Company stock on November 1, 2022 at prices ranging from $756.01 to $756.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2022 at prices ranging from $757.00 to $757.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 4 shares of Company stock on November 1, 2022 at prices ranging from $758.05 to $758.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2022 at prices ranging from $759.00 to $759.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.